Market Overview:
The global Valpromide market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of epilepsy, increasing demand for generic drugs and growing awareness about Valpromide. Based on type, the global Valpromide market is segmented into pill, capsule and suppository. The pill segment is expected to account for the largest share of the global Valpromide market in 2018. This can be attributed to its easy availability and low cost as compared to other forms of Valpromide. Based on application, the global Valpromide market is segmented into hospital, pharmacy and others.
Product Definition:
Valpromide is a drug used to treat seizures. It is important because it can help reduce the number of seizures a person has.
Pill:
Pill is a trade name for the generic drug used to treat heart failure. It is also used as an oral medication to prevent blood clots from forming in the arteries of the legs and arms. Pill was first approved by the U.S Food and Drug Administration (FDA) in 1964 for preventing blood clots from forming in patients suffering from coronary artery disease or who have recently suffered a heart attack.
Capsule:
Capsule is a small package containing medicine substance. It protects active ingredients from light, moisture, and air. Capsules are used in various medicines for the protection of drugs and their optimal delivery to targeted areas of the body. Valpromide (VPA) is an capsules used for treatment of heart failure with reduced blood flow caused due to Cardiovascular Diseases (CVDs).
Application Insights:
Hospital was the largest application segment in 2017 and is expected to witness significant growth over the forecast period. Valpromide is used for treating various health conditions, such as constipation, diarrhea, abdominal pain and nausea. It acts as a stimulant & purgative which helps in eliminating waste from the body. The product also has antidiarrheal properties which help treat chronic diarrhea caused due to infections or dietary indiscretions. These factors are anticipated to drive demand in hospital applications over the forecast period.
The pharmacy segment held around 7% of global valpromide market share in 2017 owing to increasing usage of this medication for treating constipation.
Regional Analysis:
North America dominated the global valpromide market in 2017. The presence of a large number of key players and high adoption rate for new technologies are some factors responsible for its largest share. Moreover, increasing government initiatives to improve patient safety & treatment outcomes and growing healthcare expenditure are also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions owing to rising geriatric population, improving economic conditions, expanding medical infrastructure coupled with increasing awareness about emerging therapies & treatments among patients is driving this region’s growth.
Growth Factors:
- Increasing prevalence of Valpromide-induced seizures and epilepsy
- Rising geriatric population susceptible to Valpromide-induced seizures and epilepsy
- Growing demand for better seizure control therapies
- Technological advancements in the field of seizure control therapies
- Availability of generic versions of Valpromide
Scope Of The Report
Report Attributes
Report Details
Report Title
Valpromide Market Research Report
By Type
Pill, Capsule, Suppository
By Application
Hospital, Pharmacy, Others
By Companies
China Resources Double-Crane Pharmaceutical Co., Ltd., Beijing Sail Biopharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., Shanxi Luliang Traditional Chinese Medicine Factory, Hunan Hansen Pharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Novartis Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Valpromide Market Report Segments:
The global Valpromide market is segmented on the basis of:
Types
Pill, Capsule, Suppository
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- China Resources Double-Crane Pharmaceutical Co., Ltd.
- Beijing Sail Biopharmaceutical Co., Ltd.
- Hunan Xiangzhong Pharmaceutical Co., Ltd.
- Shanxi Luliang Traditional Chinese Medicine Factory
- Hunan Hansen Pharmaceutical Co., Ltd.
- Hunan Dino Pharmaceutical Co., Ltd.
- Novartis Pharmaceuticals
Highlights of The Valpromide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pill
- Capsule
- Suppository
- By Application:
- Hospital
- Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Valpromide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Valpromide is a medication used to treat seizures. It is also used to prevent seizures in people who have had a seizure disorder for at least six months. Valpromide works by stopping the spread of seizure activity in the brain.
Some of the major players in the valpromide market are China Resources Double-Crane Pharmaceutical Co., Ltd., Beijing Sail Biopharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., Shanxi Luliang Traditional Chinese Medicine Factory, Hunan Hansen Pharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Novartis Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Valpromide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Valpromide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Valpromide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Valpromide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Valpromide Market Size & Forecast, 2020-2028
4.5.1 Valpromide Market Size and Y-o-Y Growth
4.5.2 Valpromide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pill
5.2.2 Capsule
5.2.3 Suppository
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Valpromide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Valpromide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pill
9.6.2 Capsule
9.6.3 Suppository
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pill
10.6.2 Capsule
10.6.3 Suppository
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pill
11.6.2 Capsule
11.6.3 Suppository
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pill
12.6.2 Capsule
12.6.3 Suppository
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pill
13.6.2 Capsule
13.6.3 Suppository
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Valpromide Market: Competitive Dashboard
14.2 Global Valpromide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 China Resources Double-Crane Pharmaceutical Co., Ltd.
14.3.2 Beijing Sail Biopharmaceutical Co., Ltd.
14.3.3 Hunan Xiangzhong Pharmaceutical Co., Ltd.
14.3.4 Shanxi Luliang Traditional Chinese Medicine Factory
14.3.5 Hunan Hansen Pharmaceutical Co., Ltd.
14.3.6 Hunan Dino Pharmaceutical Co., Ltd.
14.3.7 Novartis Pharmaceuticals
